Saulnier Sholler G, Eslin D, Roberts W, Kaplan J, Bergendahl G, Higgins T, Ashikaga T, Lenox S, Silberman S, Ferguson W. Phase I Trial of TPI 287 as a Single Agent and in Combination with Temozolomide (TMZ) in Patients with Refractory or Recurrent Neuroblastoma (NB) or Medulloblastoma (MB)  June 2011 ASCO Annual Meeting, Chicago, IL